
The inability to accurately predict treatment outcomes for cancer patients in terms of zzso response and zzso drug toxicity is a severe limitation inherent in current approaches to zzso Many zzso drugs are metabolically cleared by zzso zzso zzso zzso the zzso zzso expressed in zzso zzso expression exhibits marked zzso variation and is zzso in acute inflammatory zzso 

zzso To review the relevance of zzso zzso to drug metabolism in the setting of cancer and to understand how inflammation associated with zzso contributes to both this zzso and to adverse treatment zzso zzso To examine the relationship between zzso inflammation and repression of zzso and to explore methods of dosing of zzso drugs in the setting of advanced zzso 

Review of relevant literature covering both human and animal studies as well as in zzso zzso zzso 

zzso zzso in zzso expression is a major zzso factor for effective cancer treatment and methods to predict zzso drug clearance may have clinical utility in this zzso Although acute inflammation has long been zzso to repress drug zzso it is now becoming apparent that cancer patients exhibiting clinical and laboratory features of an inflammatory response have reduced expression of zzso and possibly other genes relevant to zzso drug zzso 

